Literature DB >> 31173500

YY1-Induced Upregulation of Long Noncoding RNA ARAP1-AS1 Promotes Cell Migration and Invasion in Colorectal Cancer Through the Wnt/β-Catenin Signaling Pathway.

Yaqun Ye1, Binbin Gu2, Yi Wang2, Sudan Shen2, Wei Huang2.   

Abstract

Introduction: It has been reported that long noncoding RNAs (lncRNAs) are crucial regulators in progression of human cancers, including colorectal cancer (CRC). However, the function of lncRNA ARAP1 antisense RNA 1 (ARAP1-AS1) in CRC remains unclear. Aim: The aim of this study was to investigate the function and molecular mechanism of lncRNA ARAP1-AS1 in CRC.
Results: ARAP1-AS1 was highly expressed in CRC tissues and cell lines. ARAP1-AS1 knockdown suppressed cell migration, invasion, and epithelial-mesenchymal transition (EMT). YY1 transcription factor (YY1) enhanced the transcription activity of ARAP1-AS1. The YY1/ARAP1-AS1 axis promoted CRC cell migration and invasion. YY1/ARAP1-AS1 could regulate the Wnt/β-catenin signaling pathway. Conclusions: This study revealed that YY1-induced upregulation of ARAP1-AS1 promoted cell migration, invasion, and EMT process in CRC through the Wnt/β-catenin signaling pathway.

Entities:  

Keywords:  Wnt/β-catenin signaling pathway; YY1; colorectal cancer; lncRNA ARAP1-AS1; migration

Mesh:

Substances:

Year:  2019        PMID: 31173500     DOI: 10.1089/cbr.2018.2745

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  19 in total

Review 1.  Research updates on the clinical implication of long noncoding RNA in digestive system cancers and chemoresistance.

Authors:  Xinzhi Miao; Fang Wang; Tianyun Wang; Siti Razila Abdul Razak; Muhammad Amir Yunus; Ida Shazrina Ismail
Journal:  3 Biotech       Date:  2021-09-01       Impact factor: 2.893

2.  LncRNA BBOX1-AS1 Aggravates the Development of Ovarian Cancer by Sequestering miR-361-3p to Augment PODXL Expression.

Authors:  Huiping Yao; Rui Chen; Yongxiu Yang; Juan Jiang
Journal:  Reprod Sci       Date:  2020-11-06       Impact factor: 3.060

3.  Long noncoding RNA ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 antisense RNA 1 recruits enhancer of zeste 2 polycomb repressive complex 2 subunit to promote the proliferation, migration and invasion of lung adenocarcinoma cells.

Authors:  Jinyuan Liu; Chunfeng Pan; Rongxin Lu; Shijiang Zhang
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

4.  Molecular interplay between linc01134 and YY1 dictates hepatocellular carcinoma progression.

Authors:  Zhonghou Rong; Zhiyi Wang; Xinxing Wang; Chengkun Qin; Wenmao Geng
Journal:  J Exp Clin Cancer Res       Date:  2020-04-09

Review 5.  mTORC1 as a Regulator of Mitochondrial Functions and a Therapeutic Target in Cancer.

Authors:  Karen Griselda de la Cruz López; Mariel Esperanza Toledo Guzmán; Elizabeth Ortiz Sánchez; Alejandro García Carrancá
Journal:  Front Oncol       Date:  2019-12-13       Impact factor: 6.244

6.  LncRNA ARAP1-AS1 aggravates the malignant phenotypes of ovarian cancer cells through sponging miR-4735-3p to enhance PLAGL2 expression.

Authors:  Cuiping Li; Bing Dong; Xiaomeng Xu; Yuewen Li; Yan Wang; Xingmei Li
Journal:  Cytotechnology       Date:  2021-04-03       Impact factor: 2.040

7.  Long non-coding RNA ARAP1-AS1 promotes tumorigenesis and metastasis through facilitating proto-oncogene c-Myc translation via dissociating PSF/PTB dimer in cervical cancer.

Authors:  Yao Zhang; Dan Wu; Dian Wang
Journal:  Cancer Med       Date:  2020-01-17       Impact factor: 4.452

Review 8.  The Two Sides of YY1 in Cancer: A Friend and a Foe.

Authors:  Sailu Sarvagalla; Srinivasa Prasad Kolapalli; Sivakumar Vallabhapurapu
Journal:  Front Oncol       Date:  2019-11-20       Impact factor: 6.244

9.  Long non-coding RNA ARAP1-AS1 accelerates cell proliferation and migration in breast cancer through miR-2110/HDAC2/PLIN1 axis.

Authors:  Chong Lu; Xiuhua Wang; Xiangwang Zhao; Yue Xin; Chunping Liu
Journal:  Biosci Rep       Date:  2020-04-30       Impact factor: 3.840

Review 10.  The biological implications of Yin Yang 1 in the hallmarks of cancer.

Authors:  Ian Timothy Sembiring Meliala; Rendy Hosea; Vivi Kasim; Shourong Wu
Journal:  Theranostics       Date:  2020-03-04       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.